Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Development Of Precision Medicine
3.2. Key Drivers
3.2.1. Usage Of Digital Collaboration In Exchanging Useful Information For Developing Precision Medicine
3.2.2. Identification And Characterization Of Essential Genes In The Human Genome
3.2.3. Prevalence Of Precision Medicine To Tackle Chronic Condition
3.2.4. Demand For Preventive Care
3.3. Key Restraints
3.3.1. Security Risks Associated With Data Sharing
3.3.2. Difficulty In Acquiring Pharmacotherapy Approval For A New Drug
3.3.3. Uncertainty Associated With Reimbursement And Regulatory Policies

4. Key Analytics
4.1. Impact Of Covid-19 On Precision Medicine Market
4.2. Key Investment Insights
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entries
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Technologies Related To Precision Medicine
4.7. Supply Chain Analysis
4.8. Regulatory Framework

5. Market By Application
5.1. Oncology
5.2. Infectious Diseases
5.3. Neurology/Physiatry
5.4. Cardiovascular
5.5. Lifestyle And Endocrinology
5.6. Gastroenterology
5.7. Other Applications

6. Market By Component
6.1. Applied Science
6.1.1. Genomics
6.1.1.1. Pcr
6.1.1.2. Pm Ngs
6.1.1.3. Genome Editing
6.1.1.4. Other Genomics Technologies
6.1.2. Pharmacogenomics
6.1.3. Other Applied Sciences
6.2. Precision Therapeutics
6.2.1. Clinical Trials
6.2.2. Cell Therapy
6.2.3. Drug Discovery And Research
6.2.4. Gene Therapy
6.3. Precision Diagnostics
6.3.1. Molecular Diagnostics
6.3.1.1. Non-Invasive Prenatal Testing (Nipt)
6.3.1.2. Companion Diagnostics
6.3.1.3. Liquid Biopsy
6.3.1.4. Other Molecular Diagnostics
6.3.2. Medical Imaging
6.3.2.1. Imaging Analytics
6.3.2.2. Imaging Computer-Aided Detection (Cadx)
6.4. Digital Health And Information Technology
6.4.1. Clinical Decision Support Systems (Cdss)
6.4.2. Big Data Analytics
6.4.3. It Infrastructure
6.4.4. Genomics Informatics
6.4.5. In-Silico Informatics
6.4.6. Mobile Health

7. Geographical Analysis
7.1. North America
7.1.1. Market Size & Estimates
7.1.2. Key Growth Enablers
7.1.3. Key Challenges
7.1.4. Key Players
7.1.5. Country Analysis
7.1.5.1. United States
7.1.5.2. Canada
7.2. Europe
7.2.1. Market Size & Estimates
7.2.2. Key Growth Enablers
7.2.3. Key Challenges
7.2.4. Key Players
7.2.5. Country Analysis
7.2.5.1. Germany
7.2.5.2. France
7.2.5.3. United Kingdom
7.2.5.4. Italy
7.2.5.5. Russia
7.2.5.6. Belgium
7.2.5.7. Poland
7.2.5.8. Rest Of Europe
7.3. Asia-Pacific
7.3.1. Market Size & Estimates
7.3.2. Key Growth Enablers
7.3.3. Key Challenges
7.3.4. Key Players
7.3.5. Country Analysis
7.3.5.1. China
7.3.5.2. Japan
7.3.5.3. Australia & New Zealand
7.3.5.4. India
7.3.5.5. South Korea
7.3.5.6. Thailand
7.3.5.7. Malaysia
7.3.5.8. Singapore
7.3.5.9. Rest Of Asia-Pacific
7.4. Rest Of World
7.4.1. Market Size & Estimates
7.4.2. Key Growth Enablers
7.4.3. Key Challenges
7.4.4. Key Players
7.4.5. Regional Analysis
7.4.5.1. Latin America
7.4.5.2. Middle East & Africa

8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships, Contracts/Agreements & Collaborations
8.1.4. Business Expansions/ Approvals/ Announcements
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.2. Astra Zeneca Plc
8.2.3. Biocrates Life Sciences Ag
8.2.4. Bio-Rad Laboratories Inc
8.2.5. Danaher Corporation
8.2.6. Eagle Genomics Ltd
8.2.7. Eli Lilly & Company
8.2.8. F. Hoffmann-La Roche
8.2.9. Intomics
8.2.10. Laboratory Corporation Of America Holdings
8.2.11. Nanostring Technologies
8.2.12. Novartis Ag
8.2.13. Pfizer Inc
8.2.14. Qiagen Nv
8.2.15. Quest Diagnostics Incorporated



List of Figures


Figure 1: Chronic Conditions In Patients Hospitalized With Covid-19 In The United States
Figure 2: Key Investment Insights
Figure 3: Porter’S Five Forces Analysis
Figure 4: Opportunity Matrix
Figure 5: Vendor Landscape
Figure 6: Global Precision Medicine Market, By Application, In 2020
Figure 7: Global Precision Medicine Market, By Oncology, 2021-2028 (In $ Million)
Figure 8: Global Precision Medicine Market, By Infectious Diseases, 2021-2028 (In $ Million)
Figure 9: Global Precision Medicine Market, By Neurology/Physiatry, 2021-2028 (In $ Million)
Figure 10: Global Precision Medicine Market, By Cardiovascular, 2021-2028 (In $ Million)
Figure 11: Global Precision Medicine Market, By Lifestyle And Endocrinology, 2021-2028 (In $ Million)
Figure 12: Global Precision Medicine Market, By Gastroenterology, 2021-2028 (In $ Million)
Figure 13: Global Precision Medicine Market, By Other Applications,2021-2028 (In $ Million)
Figure 14: Global Precision Medicine Market, By Component, In 2020
Figure 15: Global Precision Medicine Market, By Applied Science, 2021-2028 (In $ Million)
Figure 16: Global Applied Science Market, By Genomics, 2021-2028 (In $ Million)
Figure 17: Global Genomics Market, By Pcr, 2021-2028 (In $ Million)
Figure 18: Global Genomics Market, By Pm Ngs, 2021-2028 (In $ Million)
Figure 19: Global Genomics Market, By Genome Editing, 2021-2028 (In $ Million)
Figure 20: Global Genomics Market, By Other Genomics Technologies, 2021-2028 (In $ Million)
Figure 21: Global Applied Science Market, By Pharmacogenomics, 2021-2028 (In $ Million)
Figure 22: Biomarker’S Role In Pharmacogenomics
Figure 23: Global Applied Sciences Market, By Other Applied Sciences, 2021-2028 (In $ Million)
Figure 24: Global Precision Medicine Market, By Precision Therapeutics, 2021-2028 (In $ Million)
Figure 25: Global Precision Therapeutics Market, By Clinical Trials, 2021-2028 (In $ Million)
Figure 26: Global Precision Therapeutics Market, By Cell Therapy, 2021-2028 (In $ Million)
Figure 27: Global Precision Therapeutics Market, By Drug Discovery And Research, 2021-2028 (In $ Million)
Figure 28: Global Precision Therapeutics Market, By Gene Therapy, 2021-2028 (In $ Million)
Figure 29: Global Precision Medicine Market, By Precision Diagnostics, 2021-2028 (In $ Million)
Figure 30: Global Precision Diagnostics Market, By Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 31: Global Molecular Diagnostics Market, By Non-Invasive Prenatal Testing (Nipt), 2021-2028 (In $ Million)
Figure 32: Global Molecular Diagnostics Market, By Companion Diagnostics, 2021-2028 (In $ Million)
Figure 33: Global Molecular Diagnostics Market, By Liquid Biopsy, 2021-2028 (In $ Million)
Figure 34: Global Molecular Diagnostics Market, By Other Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 35: Global Precision Diagnostics Market, By Medical Imaging, 2021-2028 (In $ Million)
Figure 36: Global Medical Imaging Market, By Imaging Analytics, 2021-2028 (In $ Million)
Figure 37: Global Medical Imaging Market, By Imaging Computer-Aided Detection (Cadx), 2021-2028 (In $ Million)
Figure 38: Global Precision Medicine Market, By Digital Health And Information Technology, 2021-2028 (In $ Million)
Figure 39: Global Digital Health And Information Technology Market, By Clinical Decision Support Systems (Cdss), 2021-2028 (In $ Million)
Figure 40: Global Digital Health And Information Technology Market, By Big Data Analytics, 2021-2028 (In $ Million)
Figure 41: Global Digital Health And Information Technology Market, By It Infrastructure, 2021-2028 (In $ Million)
Figure 42: Global Digital Health And Information Technology Market, By Genomics Informatics, 2021-2028 (In $ Million)
Figure 43: Global Digital Health And Information Technology Market, By In-Silico Informatics, 2021-2028 (In $ Million)
Figure 44: Global Digital Health And Information Technology Market, By Mobile Health, 2021-2028 (In $ Million)
Figure 45: North America Precision Medicine Market, Country Outlook, 2020 & 2028 (In %)
Figure 46: United States Precision Medicine Market, 2021-2028 (In $ Million)
Figure 47: Canada Precision Medicine Market, 2021-2028 (In $ Million)
Figure 48: Europe Precision Medicine Market, Country Outlook, 2020 & 2028 (In %)
Figure 49: Germany Precision Medicine Market, 2021-2028 (In $ Million)
Figure 50: France Precision Medicine Market, 2021-2028 (In $ Million)
Figure 51: United Kingdom Precision Medicine Market, 2021-2028 (In $ Million)
Figure 52: Italy Precision Medicine Market, 2021-2028 (In $ Million)
Figure 53: Russia Precision Medicine Market, 2021-2028 (In $ Million)
Figure 54: Belgium Precision Medicine Market, 2021-2028 (In $ Million)
Figure 55: Poland Precision Medicine Market, 2021-2028 (In $ Million)
Figure 56: Rest Of Europe Precision Medicine Market, 2021-2028 (In $ Million)
Figure 57: Asia-Pacific Precision Medicine Market, Country Outlook, 2020 & 2028 (In %)
Figure 58: China Precision Medicine Market, 2021-2028 (In $ Million)
Figure 59: Japan Precision Medicine Market, 2021-2028 (In $ Million)
Figure 60: Australia & New Zealand Precision Medicine Market, 2021-2028 (In $ Million)
Figure 61: India Precision Medicine Market, 2021-2028 (In $ Million)
Figure 62: South Korea Precision Medicine Market, 2021-2028 (In $ Million)
Figure 63: Thailand Precision Medicine Market, 2021-2028 (In $ Million)
Figure 64: Malaysia Precision Medicine Market, 2021-2028 (In $ Million)
Figure 65: Singapore Precision Medicine Market, 2021-2028 (In $ Million)
Figure 66: Rest Of Asia-Pacific Precision Medicine Market, 2021-2028 (In $ Million)
Figure 67: Rest Of World Precision Medicine Market, Regional Outlook, 2020 & 2028 (In %)
Figure 68: Latin America Precision Medicine Market, 2021-2028 (In $ Million)
Figure 69: Middle East & Africa Precision Medicine Market, 2021-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - PRECISION MEDICINE
TABLE 2: GLOBAL PRECISION MEDICINE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: GLOBAL PRECISION MEDICINE MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: GLOBAL ONCOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: GLOBAL ONCOLOGY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: GLOBAL INFECTIOUS DISEASES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: GLOBAL INFECTIOUS DISEASES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL NEUROLOGY/PHYSIATRY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: GLOBAL NEUROLOGY/PHYSIATRY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL CARDIOVASCULAR MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: GLOBAL CARDIOVASCULAR MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL LIFESTYLE AND ENDOCRINOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: GLOBAL LIFESTYLE AND ENDOCRINOLOGY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: GLOBAL GASTROENTEROLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: GLOBAL GASTROENTEROLOGY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: GLOBAL PRECISION MEDICINE MARKET, BY COMPONENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: GLOBAL PRECISION MEDICINE MARKET, BY COMPONENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 20: GLOBAL APPLIED SCIENCE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 21: GLOBAL APPLIED SCIENCE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 22: GLOBAL APPLIED SCIENCE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 23: GLOBAL APPLIED SCIENCE MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 24: GLOBAL GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 25: GLOBAL GENOMICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 26: GLOBAL GENOMICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 27: GLOBAL GENOMICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 28: GLOBAL PCR GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 29: GLOBAL PCR GENOMICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 30: GLOBAL PM NGS GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 31: GLOBAL PM NGS GENOMICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 32: GLOBAL GENOME EDITING GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 33: GLOBAL GENOME EDITING GENOMICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 34: GLOBAL OTHER GENOMICS TECHNOLOGIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 35: GLOBAL OTHER GENOMICS TECHNOLOGIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 36: GLOBAL PHARMACOGENOMICS APPLIED SCIENCE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 37: GLOBAL PHARMACOGENOMICS APPLIED SCIENCE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 38: GLOBAL OTHER APPLIED SCIENCES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 39: GLOBAL OTHER APPLIED SCIENCES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 40: GLOBAL PRECISION THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 41: GLOBAL PRECISION THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 42: GLOBAL PRECISION THERAPEUTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 43: GLOBAL PRECISION THERAPEUTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 44: GLOBAL CLINICAL TRIALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 45: GLOBAL CLINICAL TRIALS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 46: GLOBAL CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 47: GLOBAL CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 48: GLOBAL DRUG DISCOVERY AND RESEARCH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 49: GLOBAL DRUG DISCOVERY AND RESEARCH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 50: GLOBAL GENE THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 51: GLOBAL GENE THERAPY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 52: GLOBAL PRECISION DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 53: GLOBAL PRECISION DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 54: GLOBAL PRECISION DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 55: GLOBAL PRECISION DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 56: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 57: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 58: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 59: GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 60: GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 61: GLOBAL NON-INVASIVE PRENATAL TESTING (NIPT) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 62: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 63: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 64: GLOBAL LIQUID BIOPSY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 65: GLOBAL LIQUID BIOPSY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 66: GLOBAL OTHER MOLECULAR DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 67: GLOBAL OTHER MOLECULAR DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 68: GLOBAL MEDICAL IMAGING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 69: GLOBAL MEDICAL IMAGING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 70: GLOBAL MEDICAL IMAGING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 71: GLOBAL MEDICAL IMAGING MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 72: GLOBAL IMAGING ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 73: GLOBAL IMAGING ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 74: GLOBAL IMAGING COMPUTER-AIDED DETECTION (CADX) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 75: GLOBAL IMAGING COMPUTER-AIDED DETECTION (CADX) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 76: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 77: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 78: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 79: GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 80: GLOBAL CLINICAL DECISION SUPPORT SYSTEMS (CDSS) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 81: GLOBAL CLINICAL DECISION SUPPORT SYSTEMS (CDSS) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 82: GLOBAL BIG DATA ANALYTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 83: GLOBAL BIG DATA ANALYTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 84: GLOBAL IT INFRASTRUCTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 85: GLOBAL IT INFRASTRUCTURE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 86: GLOBAL GENOMICS INFORMATICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 87: GLOBAL GENOMICS INFORMATICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 88: GLOBAL IN-SILICO INFORMATICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 89: GLOBAL IN-SILICO INFORMATICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 90: GLOBAL MOBILE HEALTH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 91: GLOBAL MOBILE HEALTH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 92: GLOBAL PRECISION MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 93: GLOBAL PRECISION MEDICINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 94: NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 95: NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 96: LEADING PLAYERS OPERATING IN NORTH AMERICA PRECISION MEDICINE MARKET
TABLE 97: EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 98: EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 99: LEADING PLAYERS OPERATING IN EUROPE PRECISION MEDICINE MARKET
TABLE 100: ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 101: ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 102: LEADING PLAYERS OPERATING IN ASIA-PACIFIC PRECISION MEDICINE MARKET
TABLE 103: REST OF WORLD PRECISION MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 104: REST OF WORLD PRECISION MEDICINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 105: LEADING PLAYERS OPERATING IN REST OF WORLD PRECISION MEDICINE MARKET
TABLE 106: LIST OF MERGERS & ACQUISITIONS
TABLE 107: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS
TABLE 108: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 109: LIST OF BUSINESS EXPANSIONS & DIVESTITURES